Akkodis Awarded Global BioStatistics Managed Services Contract by Biopharma Leader to Drive Innovation
The Smart Industry leader provides AI-powered statistical studies and statistical programming tools to accelerate the clients’ non-clinical and clinical trial processes while ensuring roll-out across more than 15 countries.
1 minutes
28th of March, 2024
Akkodis, a global digital engineering company and Smart Industry leader, has been awarded a three-year managed services contract by a leading global biopharmaceutical company. The contract focuses on providing statistical and strategic programming activities for pre-clinical and clinical research, marking an extension of Akkodis' ongoing global partnership.
Akkodis supports the client in its quest to deliver innovative technology, services and solutions for its products. As part of this engagement, the Global Biostat Center of Excellence (CoE) oversees the following:
- Management of global cross-talent capacity and service, including the Biostat Academy
- Quality assurance and regulatory compliance driven by the highest compliance and operational standards
- Cost-effectiveness offering flexible pricing models across the globe with a total cost of ownership reduction focus.
- Time-saving initiatives and efficiency enhancements, while also managing a specialized team that allows the client to redirect its focus to other aspects of its research or projects
- Pioneering a transformative vision centered on innovation and flawless implementation of automation processes, all aimed at enhancing the value of our services
"As a Smart Industry leader, Akkodis takes pride in being a trusted partner to clients who rely on our deep industry expertise and game-changing solutions to realize their ambition of driving better outcomes for patients, in this case, by accelerating drug delivery to the market”, says Isabelle Stewart, SVP, Global Life Sciences & Healthcare, Akkodis.
Contact: akkodis.global-biostat-coe@akkodis.com